1.70
price down icon7.10%   -0.13
after-market After Hours: 1.68 -0.02 -1.18%
loading
Redhill Biopharma Ltd Adr stock is traded at $1.70, with a volume of 70,271. It is down -7.10% in the last 24 hours and up +12.58% over the past month. Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
See More
Previous Close:
$1.83
Open:
$1.85
24h Volume:
70,271
Relative Volume:
0.05
Market Cap:
$5.66M
Revenue:
$35.75M
Net Income/Loss:
$11.57M
P/E Ratio:
-0.4466
EPS:
-3.8069
Net Cash Flow:
$-26.25M
1W Performance:
-10.53%
1M Performance:
+12.58%
6M Performance:
-38.85%
1Y Performance:
-79.01%
1-Day Range:
Value
$1.69
$1.8952
1-Week Range:
Value
$1.69
$2.16
52-Week Range:
Value
$1.06
$9.00

Redhill Biopharma Ltd Adr Stock (RDHL) Company Profile

Name
Name
Redhill Biopharma Ltd Adr
Name
Phone
-
Name
Address
-
Name
Employee
35
Name
Twitter
@RedHillBio
Name
Next Earnings Date
2025-08-29
Name
Latest SEC Filings
Name
RDHL's Discussions on Twitter

Compare RDHL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.70 6.09M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Redhill Biopharma Ltd Adr Stock (RDHL) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-31-21 Initiated Cantor Fitzgerald Overweight
May-18-21 Initiated H.C. Wainwright Buy
Sep-11-20 Initiated BTIG Research Buy
Jul-12-19 Upgrade WBB Securities Buy → Strong Buy
Mar-12-19 Upgrade WBB Securities Speculative Buy → Buy
Jan-26-18 Initiated Nomura Buy
Oct-06-17 Initiated Seaport Global Securities Buy
Oct-04-17 Reiterated H.C. Wainwright Buy
Feb-24-17 Reiterated FBR & Co. Outperform
Jul-27-16 Reiterated FBR Capital Outperform
Sep-29-15 Initiated Nomura Buy
Jul-29-15 Reiterated ROTH Capital Buy
Jun-17-15 Reiterated H.C. Wainwright Buy
Jun-15-15 Reiterated ROTH Capital Buy
View All

Redhill Biopharma Ltd Adr Stock (RDHL) Latest News

pulisher
Oct 06, 2025

RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia® - PR Newswire

Oct 06, 2025
pulisher
Sep 29, 2025

RedHill Biopharma stock surges after court upholds $10M judgment - Investing.com

Sep 29, 2025
pulisher
Sep 29, 2025

RedHill Biopharma stock surges after court upholds $10M judgment By Investing.com - Investing.com South Africa

Sep 29, 2025
pulisher
Sep 29, 2025

Is RDHL Poised for Rebound? Analyzing Financial Moves - StocksToTrade

Sep 29, 2025
pulisher
Sep 29, 2025

RedHill Wins New York Supreme Court Appeal, Upholding $10 Million Summary Judgment Against Kukbo - Sahm

Sep 29, 2025
pulisher
Sep 05, 2025

RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights - Placera.se

Sep 05, 2025
pulisher
Aug 18, 2025

RedHill Received Talicia® Licensing Payments Totaling $1.1 Million - PR Newswire

Aug 18, 2025
pulisher
Aug 14, 2025

RedHill Biopharma receives Nasdaq extension to regain compliance by October - Investing.com South Africa

Aug 14, 2025
pulisher
Jul 21, 2025

Redhill Biopharma stock soars after FDA provides positive pathway for Crohn’s drug - Investing.com India

Jul 21, 2025
pulisher
May 02, 2025

RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress - Finansavisen

May 02, 2025
pulisher
Apr 22, 2025

Taking the lead: Redhill Biopharma Ltd. ADR (RDHL) - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

The time has not yet come to remove your chips from the table: Hertz Global Holdings Inc (HTZ) - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

A significant driver of top-line growth: Alexandria Real Estate Equities Inc (ARE) - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

Redhill Biopharma Ltd. ADR [RDHL] Insider Activity: An Update for Investors - knoxdaily.com

Apr 22, 2025
pulisher
Apr 17, 2025

RedHill Biopharma faces Nasdaq non-compliance issue - Investing.com

Apr 17, 2025
pulisher
Apr 17, 2025

RedHill Biopharma faces Nasdaq non-compliance issue By Investing.com - Investing.com India

Apr 17, 2025
pulisher
Apr 17, 2025

RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - PR Newswire

Apr 17, 2025
pulisher
Apr 16, 2025

Redhill Biopharma stock hits 52-week low at $1.72 amid market challenges - Investing.com

Apr 16, 2025
pulisher
Apr 02, 2025

Redhill Biopharma stock hits 52-week low at $2.47 amid steep annual decline - Investing.com

Apr 02, 2025
pulisher
Mar 18, 2025

RedHill Biopharma targets UK approval for H. pylori therapy - Investing.com

Mar 18, 2025
pulisher
Mar 12, 2025

Redhill Biopharma Ltd. ADR (RDHL)’s Stock Price Falls Due To Weak Fundamental Momentum - Marketing Sentinel

Mar 12, 2025
pulisher
Mar 11, 2025

Redhill Biopharma stock hits 52-week low at $3 amid steep annual decline - Investing.com

Mar 11, 2025
pulisher
Feb 25, 2025

Hyloris secures global rights to RedHill's RHB-102 - Investing.com

Feb 25, 2025
pulisher
Feb 21, 2025

Redhill Biopharma stock hits 52-week low at $4.79 - Investing.com

Feb 21, 2025
pulisher
Feb 04, 2025

RedHill tests opaganib with Bayer's drug in prostate cancer study - Investing.com

Feb 04, 2025
pulisher
Jan 21, 2025

RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published - PR Newswire

Jan 21, 2025
pulisher
Aug 21, 2024

Talicia® Launched in the United Arab Emirates - PR Newswire

Aug 21, 2024
pulisher
Aug 16, 2024

RedHill Biopharma Announces Plan to Implement ADS Ratio Change - PR Newswire

Aug 16, 2024
pulisher
Jul 22, 2024

RedHill Biopharma finalizes agreement to enhance cash position - Investing.com

Jul 22, 2024
pulisher
Jan 25, 2024

RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 - PR Newswire

Jan 25, 2024
pulisher
Jan 11, 2024

Balancing Acidity: Exploring the Proton Pump Inhibitors Market - openPR.com

Jan 11, 2024
pulisher
Nov 29, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 29, 2023
pulisher
Aug 01, 2023

RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S. - Barchart.com

Aug 01, 2023
pulisher
Jul 21, 2023

RedHill Biopharma Announces Registered Direct Offering and Warrant Exercise for $3.8 Million Gross Proceeds - Barchart.com

Jul 21, 2023
pulisher
Jul 06, 2023

Phil and RedHill Biopharma Partner to Increase Access to Talicia® - Business Wire

Jul 06, 2023
pulisher
Mar 17, 2023

RedHill Biopharma to Implement ADS Ratio Change to 1:400 By Investing.com - Investing.com India

Mar 17, 2023
pulisher
Feb 24, 2023

Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 24, 2023
pulisher
Nov 08, 2022

Extremely Robust COVID-19 Clinical Trial Pipeline With 420+ Key Companies Expected to Change the Pace of the COVID-19 Treatment - PR Newswire UK

Nov 08, 2022
pulisher
Oct 26, 2022

RedHill presents New Talicia® and Movantik® data analyses at ACG 2022 - EurekAlert!

Oct 26, 2022
pulisher
Jan 06, 2022

RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia® for the United Arab Emirates - PR Newswire

Jan 06, 2022
pulisher
May 24, 2021

RedHill Biopharma Presents Analyses of Movantik Onset of Action and Symptom Improvement at DDW 2021 - BioSpace

May 24, 2021
pulisher
Jan 11, 2021

RedHill's Partner Cosmo Pharmaceuticals Successfully Completes Phase 2 Study of Rifamycin SV-MMX 600mg in IBS-D - PR Newswire

Jan 11, 2021
pulisher
Dec 07, 2020

RedHill Biopharma Extends Talicia® Unrestricted National and Regional Commercial Coverage to Over 40 Million Additional Americans - Stock Titan

Dec 07, 2020
pulisher
Jan 21, 2020

RedHill Biopharma to Focus Commercial Efforts on Talicia® - GlobeNewswire

Jan 21, 2020
pulisher
Nov 04, 2019

RedHill Biopharma Announces FDA Approval of Talicia® for Treatment of H. pylori in Adults - GlobeNewswire

Nov 04, 2019
pulisher
May 28, 2019

RedHill Biopharma: TALICIA Launch For H. Pylori In Sight - Investing.com

May 28, 2019
pulisher
Sep 04, 2018

RedHill Biopharma's Drug Pipeline May Merit Substantial Upside, And Potential Catalysts Are On The Horizon - Seeking Alpha

Sep 04, 2018
pulisher
Dec 14, 2016

S&W Seed Company (SANW): How Does It Stack Up Against Its Peers? - Insider Monkey

Dec 14, 2016
pulisher
Jul 15, 2015

RedHill Biopharma files for further Nasdaq offering - גלובס

Jul 15, 2015
pulisher
Jun 16, 2015

Redhill Biopharma (RDHL) Stock Price, News & Analysis - MarketBeat

Jun 16, 2015

Redhill Biopharma Ltd Adr Stock (RDHL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Cap:     |  Volume (24h):